ACHV

Achieve Life Sciences (ACHV)

About Achieve Life Sciences (ACHV)

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Details

Daily high

$5.30

Daily low

$4.75

Price at open

$4.95

52 Week High

$6.02

52 Week Low

$1.96

Market cap

271.5M

Dividend yield

0.00%

Volume

4.2M

Avg. volume

1.9M

P/E ratio

-3.94

Achieve Life Sciences News